NO20011173L - Fremgangsmåter og preparater for å öke tarmabsorpsjon av fettstoffer - Google Patents

Fremgangsmåter og preparater for å öke tarmabsorpsjon av fettstoffer

Info

Publication number
NO20011173L
NO20011173L NO20011173A NO20011173A NO20011173L NO 20011173 L NO20011173 L NO 20011173L NO 20011173 A NO20011173 A NO 20011173A NO 20011173 A NO20011173 A NO 20011173A NO 20011173 L NO20011173 L NO 20011173L
Authority
NO
Norway
Prior art keywords
fats
preparations
methods
intestinal absorption
increasing intestinal
Prior art date
Application number
NO20011173A
Other languages
English (en)
Other versions
NO20011173D0 (no
Inventor
David W Yesair
Original Assignee
Biomolecular Products Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biomolecular Products Inc filed Critical Biomolecular Products Inc
Publication of NO20011173D0 publication Critical patent/NO20011173D0/no
Publication of NO20011173L publication Critical patent/NO20011173L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/465—Hydrolases (3) acting on ester bonds (3.1), e.g. lipases, ribonucleases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y301/00—Hydrolases acting on ester bonds (3.1)
    • C12Y301/01—Carboxylic ester hydrolases (3.1.1)
    • C12Y301/01004—Phospholipase A2 (3.1.1.4)

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Oppfinnelse tilveiebringer fremgangsmåter for å øke fett- absorpsjon fra tarmkanalen ved å øke mengden lysofosfatidyl- cholin i tarmkanalen. Ethvert middel som øker intestinal lysofosfatidylcholin kan anvendes, foretrukket dem som administreres oralt til individet.
NO20011173A 1998-09-08 2001-03-07 Fremgangsmåter og preparater for å öke tarmabsorpsjon av fettstoffer NO20011173L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US9943098P 1998-09-08 1998-09-08
PCT/US1999/020427 WO2000013689A1 (en) 1998-09-08 1999-09-07 Methods and compositions for increasing intestinal absorption of fats

Publications (2)

Publication Number Publication Date
NO20011173D0 NO20011173D0 (no) 2001-03-07
NO20011173L true NO20011173L (no) 2001-05-08

Family

ID=22274976

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20011173A NO20011173L (no) 1998-09-08 2001-03-07 Fremgangsmåter og preparater for å öke tarmabsorpsjon av fettstoffer

Country Status (13)

Country Link
US (1) US6426069B1 (no)
EP (1) EP1119360B1 (no)
JP (1) JP4700193B2 (no)
CN (1) CN1321089A (no)
AT (1) ATE347371T1 (no)
AU (1) AU771901B2 (no)
CA (1) CA2343116C (no)
DE (1) DE69934325T2 (no)
IL (2) IL141801A0 (no)
NO (1) NO20011173L (no)
NZ (1) NZ510536A (no)
WO (1) WO2000013689A1 (no)
ZA (1) ZA200102268B (no)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2788500C (en) * 2001-10-11 2017-08-01 Biomolecular Products, Inc. Modifications of solid 3-sn-phosphoglycerides
ES2355890T3 (es) 2002-04-05 2011-04-01 Societe des Produits Nestlé S.A. Composiciones y métodos para promocionar la asimilación de lípidos en los animales domésticos.
DE10217555A1 (de) * 2002-04-19 2004-02-19 Degussa Bioactives Deutschland Gmbh Physiologisch verträgliche, Phospholipid-haltige, stabile und harte Matrix
DK1594544T3 (en) * 2003-01-31 2016-07-25 Los Angeles Childrens Hospital ORAL COMPOSITIONS OF FENRETINIDE WHICH HAVE INCREASED BIOTAILABILITY AND PROCEDURES FOR USING IT
US7758884B2 (en) * 2005-01-28 2010-07-20 Kemin Industries, Inc. Formulation for increasing the deposition of dietary carotenoids in eggs
EP1688049A1 (de) * 2005-02-03 2006-08-09 findusFit Sportdiätetika GmbH Diätetisches Lebensmittel
FR2918846B1 (fr) 2007-07-20 2013-07-26 Isl Innovation Sante Lipides Composition alimentaire pour ameliorer la digestibilite des lipides alimentaires
CN103179990B (zh) * 2010-10-22 2015-02-04 学校法人福冈大学 应用了对胃上皮性肿瘤(腺瘤、胃癌)的诊断有用的白色不透明物质的内窥镜观察法及诊断能力改善组合物
WO2012068169A2 (en) * 2010-11-15 2012-05-24 Texas Tech University Substance for increasing the production of a specific acyl-chain dihydroceramide(s) for improving the effectiveness of cancer treatments
BR112021002490A2 (pt) * 2018-09-21 2021-10-19 Société des Produits Nestlé S.A. Composições e métodos para o tratamento de insuficiência pancreática exócrina (ipe)

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4874795A (en) * 1985-04-02 1989-10-17 Yesair David W Composition for delivery of orally administered drugs and other substances
US4849132A (en) 1986-05-16 1989-07-18 Asahi Denka Kogyo Kabushiki Kaisha Surfactant composition having improved functions
ATE121618T1 (de) 1990-08-13 1995-05-15 David W Yesair Gemischte lipid-bicarbonat-kolloidale partikel zur abgabe von arzneien und kalorien.
US5571517A (en) 1990-08-13 1996-11-05 Yesair; David W. Mixed lipid-bicarbonate colloidal particles for delivering drugs or calories
US5302400A (en) * 1992-06-22 1994-04-12 Digestive Care Inc. Preparation of gastric acid-resistant microspheres containing digestive enzymes and buffered-bile acids
JPH08143469A (ja) * 1994-11-14 1996-06-04 Amano Pharmaceut Co Ltd 膵外分泌機能不全症治療剤
ATE204746T1 (de) * 1995-06-06 2001-09-15 Biomolecular Products Inc Gemischte lipid-bicarbonat kolloidale partikel zur abgabe von arzneistoffen oder kalorien
US5716814A (en) 1996-02-02 1998-02-10 Biomolecular Products, Inc. Methods for making lysophosphatidylcholine
CA2265631A1 (en) 1996-09-11 1998-03-19 Elizabeth Shanahan-Prendergast Therapeutic formulations containing venom or venom anti-serum either alone or in combination for the therapeutic prophylaxis and therapy of neoplasms

Also Published As

Publication number Publication date
AU5705299A (en) 2000-03-27
CA2343116A1 (en) 2000-03-16
EP1119360A4 (en) 2003-06-04
IL141801A0 (en) 2002-03-10
CA2343116C (en) 2008-11-18
JP4700193B2 (ja) 2011-06-15
US6426069B1 (en) 2002-07-30
ATE347371T1 (de) 2006-12-15
JP2002524417A (ja) 2002-08-06
DE69934325T2 (de) 2007-07-05
WO2000013689A1 (en) 2000-03-16
DE69934325D1 (de) 2007-01-18
EP1119360A1 (en) 2001-08-01
AU771901B2 (en) 2004-04-08
NZ510536A (en) 2003-07-25
IL141801A (en) 2009-02-11
ZA200102268B (en) 2001-09-19
CN1321089A (zh) 2001-11-07
NO20011173D0 (no) 2001-03-07
EP1119360B1 (en) 2006-12-06

Similar Documents

Publication Publication Date Title
IS5566A (is) Afurðir úr karótínsskyldum fituefnahlutum sæbjúgna og aðferðir við notkun þeirra
NO20011173L (no) Fremgangsmåter og preparater for å öke tarmabsorpsjon av fettstoffer
EP1435946B8 (en) Linked biaryl compounds
IS4720A (is) Aðferð og lyfjablanda til að stýra styrk lípíða
DE60136490D1 (de) Sn-38-lipidkomplexe und verfahren zu ihrer verwendung
IS2595B (is) Prótínblanda og ferli til að einangra prótínblöndu úr vöðvavef
HK1152336A1 (en) Diagnosis and treatment of multiple sulfatase deficiency and others using a formylglycine generating enzyme (fge) -(fge)
DK0892035T3 (da) Flerfaseemulsion og fremgangsmåde til fremstilling heraf
DK0785773T3 (da) Etherlipidliposomer og deres terapeutiske anvendelse
MX9606503A (es) Inhibidores de pla2 y su uso para la inhibicion de la absorcion del colesterol interno.
NO20024722D0 (no) Stivelses-subtyper og lipid metabolisme
BRPI0309421B8 (pt) método de preparar um gênero alimentício e composição para tratar ou prevenir hipercolesterolemia
DE69628489D1 (de) Verfahren zur Herstellung von RTV-Einkomponenten-Siliconelastomerzusammensetzungen
DE69630666D1 (de) Wirkstoff für verbesserten fettstoffwechsel
PL336298A1 (en) Method of obtaining 2-aryl-3-aryl-halopyridines useful as cox-2 inhibitors
NO975504D0 (no) Fremgangsmåte for påvisning av forbindelser som modulerer virkningene av fettproteinet
IT1293067B1 (it) Composizione farmaceutica per il trattamento di patologie causate da alterato metabolismo lipidico
AU2002212770A1 (en) Apparatus for developing brain with audio-visual stimulus
WO2004006731A3 (de) Bilderrahmen
WO2005016277A3 (en) Arylsulfonamidobenzylic compounds
IL139144A0 (en) Mycobacterial inhibitors
NO992107D0 (no) FremgangsmÕte for pÕvisning av forbindelser som modulerer effekten av fett (OB) proteinet
WO2000027429A3 (en) Vaccine against papillomatous digital dermatitis (pdd)
EP0973390A4 (en) COMPOUNDS RELATED TO RETINOIDS FOR INHIBITING MEDICAL ENDOTHELIN-1 OVERPRODUCTION
AU2001244765A1 (en) Method for displaying results of internet search engine

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application